Literature DB >> 7019229

Multihormonal regulation of surfactant synthesis by human fetal lung in vitro.

C R Mendelson, J M Johnston, P C MacDonald, J M Snyder.   

Abstract

Explants prepared from the lung tissue of human abortuses of 20-22 weeks gestational age were incubated in defined medium without serum. These tissues developed the capacity for surfactant synthesis within 4 days. The ductular epithelium differentiated into type II pneumonocytes that contained numerous lamellar bodies. These morphological changes were accompanied by an increase in the rate of choline incorporation into phosphatidylcholine as well as an increase in the phosphatidylcholine content of the explants. Cortisol (0.2 micrograms/ml) plus PRL (2.5 micrograms/ml), when added to the medium from the beginning of the culture period, caused a 2- to 3-fold increase in the rate of choline incorporation into phosphatidylcholine, as measured on the second, fourth, sixth, and eighth days of incubation, as well as an increase in the phosphatidylcholine content of the explants. However, when administered alone, neither cortisol nor PRL affected phosphatidylcholine synthesis. In explants incubated with cortisol plus PRL there also was a stimulation of lamellar body secretion into the prealveolar ducts. The lamellar bodies in epithelial cells were larger in cortisol- plus PRL-treated tissue than those in nontreated tissues. Increases in phosphatidylcholine synthesis and lamellar body secretion also were observed in tissues incubated with insulin (2.5 micrograms/ml), cortisol, and PRL in combination or with insulin and cortisol in combination. The stimulatory effect of cortisol plus insulin on phosphatidylcholine synthesis, however, was significantly less than that of cortisol plus PRL or cortisol plus insulin plus PRL. It is suggested that human fetal lung development is under multihormonal control and that PRL and cortisol serve to increase surfactant synthesis and secretion.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7019229     DOI: 10.1210/jcem-53-2-307

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development.

Authors:  M Freemark; P Driscoll; R Maaskant; A Petryk; P A Kelly
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  Glucocorticoids both stimulate and inhibit production of pulmonary surfactant protein A in fetal human lung.

Authors:  H G Liley; R T White; B J Benson; P L Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Permissive effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms.

Authors:  Kazi Nazrul Islam; Carole R Mendelson
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  Development of human fetal lung in organ culture compared with in utero ontogeny.

Authors:  D Cossar; J Bell; M Lang; R Hume
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

5.  Optimization of fetal lung organ culture for surfactant biosynthesis.

Authors:  E Doucet; J Bourbon; M Rieutort; L Marin; C Tordet
Journal:  In Vitro Cell Dev Biol       Date:  1987-03

6.  Regulation of pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung.

Authors:  P L Ballard; S Hawgood; H Liley; G Wellenstein; L W Gonzales; B Benson; B Cordell; R T White
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Thyroid hormone stimulation of phosphatidylcholine synthesis in cultured fetal rabbit lung.

Authors:  P L Ballard; M L Hovey; L K Gonzales
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Glucocorticoid genes and the developmental origins of asthma susceptibility and treatment response.

Authors:  Sunita Sharma; Alvin T Kho; Divya Chhabra; Weiliang Qiu; Roger Gaedigk; Carrie A Vyhlidal; J Steven Leeder; Albino Barraza-Villarreal; Stephanie J London; Frank Gilliland; Benjamin A Raby; Scott T Weiss; Kelan G Tantisira
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.